Time-related changes in potential factors involved in hepatocarcinogenesis by DDT were investigated in a 4-week and a 2-year feeding studies of p,p'-DDT with F344 rats. In the 4-week study with males at doses of 50, 160, and 500 ppm, cell proliferation and gap junctional intercellular communication (GJIC) were examined after 1, 2, 3, 7, 14, and 28 days. Cell proliferation was enhanced within 3 days at any dose level, but returned to normal after 7 days, whereas GJIC was inhibited throughout the study. In the 2-year study with both sexes at doses of 5, 50, and 500 ppm, cell proliferation, GJIC, enzyme induction, and oxidative stress were investigated after 26, 52, 78, and 104 weeks. Males and females showed an inhibition of GJIC and increases in P450 isozymes (CYP2B1 and CYP3A2) in a dose-dependent manner at all time points, but no significant change in cell proliferation. Lipid peroxide for males at 50 and 500 ppm and 8-hydroxydeoxyguanosine for both sexes at 500 ppm were elevated throughout the study. Histologically, eosinophilic foci and hepatocellular adenomas increased in males at 50 ppm and both sexes at 500 ppm. Hepatocellular carcinomas also developed in males at 500 ppm. These results indicate that DDT may induce eosinophilic foci as a result of oxidative DNA damage and leads them to neoplasms in combination with its mitogenic activity and inhibitory effect on GJIC. Oxidative stress could be a key factor in hepatocarcinogenesis by DDT.
Bannasch P., Zerban H., Hacker HJ (1985). Foci of altered hepatocytes, rat. In: Monographs on Pathology of Laboratory Animals, Digestive System, Jones TC, Mohr U , Hunt RD (eds). Springer-Verlag, Berlin, pp 10—30.
2.
Beer DG, Neveu MJ (1990). Proto-oncogene and gap-junction protein expression in rodent liver neoplasms. In: Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons, Stevenson DE, McClain RM, Popp JA, Slaga TJ , Ward JM, Pitot HC (eds). Wiley-Liss, New York , pp 293—309.
3.
Büsser M-T., Lutz WK ( 1987). Stimulation of DNA synthesis in rat and mouse liver by various tumor promoters. Carcinogenesis8: 1433—1437.
4.
Butterworth BE, Conolly RB, Morgan KT (1995). A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments . Cancer Lett93: 129—146.
5.
Clayson DB, Mehta R., Iverson F. (1994). Oxidative DNA damage—The effects of certain genotoxic and operationally non-genotoxic carcinogens. Mutation Res317: 25—42.
6.
Flodström S. , Hemming H., Wärngård L., Ahlborg UG (1990). Promotion of altered hepatic foci development in rat liver, cytochrome P450 enzyme induction and inhibition of cell-cell communication by DDT and some structurally related organohalogen pesticides. Carcinogenesis11: 1413— 1417.
7.
Foley J., Ton T., Maronpot R., Butterworth B., Goldsworthy TL (1993). Comparison of proliferating cell nuclear antigen to tritiated thymidine as amarker of proliferating hepatocytes in rats. Environ Health Perspect101(Suppl 5): 199—205.
8.
Gad SC, Weil CS ( 1994). Statistics for toxicologists. In: Principles and Methods of Toxicology, Hayes AW (ed). Raven Press, New York, pp 221— 274.
9.
Goldsworthy TL, Morgan KT, Popp JA, Butterworth BE (1991). Guidelines for measuring chemically induced cell proliferation in specific rodent target organs. In: Chemically Induced Cell Proliferation: Implications for Risk Assessment. Wiley-Liss, pp 253—284.
10.
Goodman DG, Maronpot RR, Newberne PM, Popp JA, Squire RA (1994). Proliferative and selected other lesions in the liver of rats. In: Guides for Toxicologic Pathology (G1-5) . STP/ARP/AFIP, Washington, DC, pp 1—15.
11.
Harada T., Maronpot RR, Morris RW, Stitzel KA, Boorman GA (1989). Morphological and stereological characterization of hepatic foci of cellular alteration in control Fischer 344 rats. Toxicol Pathol17: 579—593.
12.
Harada T., Maronpot RR, Morris RW, Boorman GA (1989). Observations on altered hepatocellular foci in National Toxicology Program 2-year carcinogenicity studies in rats. Toxicol Pathol17: 690—708.
13.
Harada T., Maronpot RR, Morris RW, Boorman GA (1990). Effects of mononuclear cell leukemia on altered hepatocellular foci in Fischer 344 rats. Vet Pathol27: 110—116.
14.
International Agency for Research on Cancer ( 1991). Occupational exposures in insecticide application, and some pesticides. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (vol 53). IARC , Lyon, pp 179—249.
15.
ImaidaK., Tatematsu M., Kato T., TsudaH., Ito N. (1989). Advantages and limitations of stereological estimation of placental glutathione S-transferase-positive rat liver foci by computerized three-dimensional reconstruction. Jpn J Cancer Res80: 326—330.
16.
Ito N., Tsuda H., Tatematsu M., Inoue T., Tagawa Y., Aoki T., Uwagawa T., Kagawa M., Ogiso T., Masui T., Imaida K., Fukushima S., Asamoto M. (1988). Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats—An approach for a new medium-term bioassay system. Carcinogenesis9: 387— 394.
17.
Jansen LAM , Jongen WMF (1996). The use of initiated cells as a test system for detection of inhibitors of gap junctional intercellular communication. Carcinogenesis17: 333—339.
18.
Japanese Association for Laboratory Animal Science (1987). Guidelines for animal experimentation . Exp Anim36: 285—288.
19.
Klaunig JE, Ruch RJ ( 1987). Strain and species effects on the inhibition of hepatocyte intercellular communication by liver tumor promoters. Cancer Lett36: 161—168.
20.
Krutovskikh VA, Mesnil M., Mazzoleni G., Yamasaki H. (1995). Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo . Lab Invest72: 571—577.
21.
Loewenstein WR (1979). Junctional intercellular communication and the control of growth. Biochim Biophys Acta560: 1—65.
22.
Lubet RA, Mayer RT, Cameron JW, Nims RW, Burke MD, Wolff T., Guengerich FP (1985). Dealkylation ofpentoxyresorufin: A rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys238: 43—48.
23.
Lubet RA, Dragnev KH, Chauhan DP, Nims RW, Diwan BA, Ward JM, Jones CR, Rice JM, Miller MS (1992). A pleiotropic response to phenobarbital-type enzyme inducers in the F344/NCr rat. Biochem Pharmacol43: 1067—1078.
24.
Nims RW, Lubet RA, Fox SD, Jones CR, Thomas PE, Reddy AB, Kocarek TA (1998). Comparative pharmacodynamics of CYP2B induction by DDT, DDE, and DDD in male rat liver and cultured rat hepatocytes. J Toxicol Environ Health53: 455—457.
25.
Parke DV, Ioannides C. (1990). Role of cytochromes P-450 in mouse liver tumor production. In: Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons, Stevenson DE, McClain RM, Popp JA, Slaga TJ, Ward JM, Pitot HC (eds). Wiley-Liss, New York , pp 215—230.
26.
Parkinson A. (1996). An overview of current cytochrome P450 technology for assessing the safety and efficacy of new materials . Toxicol Pathol24: 45—57.
27.
Plaa GL, Charbonneau M. (1994). Detection and evaluation of chemically induced liver injury. In: Principles and Methods of Toxicology, Hayes AW (ed). Raven Press, New York, pp 839—869.
28.
Sato M., Kitahori Y., Nakagawa Y., Konishi N., Cho M., Hiasa Y. (1998). Formation of 8-hydroxydeoxyguanosine in rat kidney DNA after administration of N-ethyl-N-hydroxyethylnitrosamine. Cancer Lett124: 111— 118.
29.
Schulte-Hermann R., Schuppler J., Timmermann-Trosiener I., Ohde G., Bursch W., Berger H. (1983). The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver. Environ Health Perspect50: 185—194.
30.
Schulte-Hermann R., Bursch W., Grasl-Kranpp B., Huber W., Parzefall W. (1994). Nongenotoxic carcinogenesis in the liver. In: Nongenotoxic Carcinogenesis, Cockburn A, Smith L (eds). Springer-Verlag, Berlin, pp 109— 120.
31.
Sierra-Santoyo A., Hernández M., Albores A., Cebrián ME (2000). Sex-dependent regulation of hepatic cytochrome P-450 by DDT. Toxicol Sci54: 81—87.
32.
Simic MG (1988). Mechanisms of inhibition of free-radical processes in mutagenesis and carcinogenesis. Mutation Res202: 377—386.
33.
Ströbel P., Klimek F., Zerban H., Kopp-Schneider A., Bannasch P. (1998). Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine . Carcinogenesis19: 2069—2080.
34.
Thurman JD, Bucci TJ, Hart RW, Turturro A. (1994). Survival, body weight, and spontaneous neoplasms in ad libitum—fed and food-restricted Fischer-344 rats. Toxicol Pathol22: 1—9.
35.
Toh YC (1973). Physiological and biochemical reviews of sex differences and carcinogenesis with particular reference to the liver. Adv Cancer Res18: 155—209.
36.
Tomiyama N. , Tsuji H., Watanabe M., Takeda M., Harada T., Kobayashi H. (2000). High-performance liquid chromatographic method for determination of DDT and its degradation products in rat plasma, liver and brain: Validation and application to a pharmacokinetic study. J Chromatography B 748: 361—368.
37.
Watanabe T. , Katsura Y., Yoshitake A., Masataki H., Mori T. (1994). IPAP: Image processor for analytical pathology. J Toxicol Pathol7: 353— 361.
38.
Whysner J., Ross PM, Williams GM (1996). Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Phamacol Ther71(1/2): 153—191.
39.
Williams GM (1990). Epigenetic mechanisms of liver tumor promotion . In: Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons , Stevenson DE, McClain RM, Popp JA, Slaga TJ, Ward JM, Pitot HC (eds). Wiley-Liss, New York , pp 131—145.
40.
Yamasaki H. (1996). Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens . Mutation Res365: 91—105.
